Study sheds light on cancer spread - Cancer Research UK - News & Resources

Study sheds light on cancer spread Cancer Research UK - News & Resources, UK - 7 hours ago In order to investigate how rogue cancer cells put down roots and form secondary tumours, the researchers carried out a series of studies in mice. ...

DOR BioPharma Receives SPA Clearance From the FDA to Begin ... - CNNMoney.com

DOR BioPharma Receives SPA Clearance From the FDA to Begin ... CNNMoney.com - Jan 5, 2009 The second trial was a 129-patient pivotal Phase 3 multi-center clinical trial of orBec® conducted at 16 leading bone marrow/stem cell transplantation ...

Focus on the World Special Purpose Needles Market - MarketWatch (press release)

Focus on the World Special Purpose Needles Market MarketWatch (press release) - Jan 6, 2009 The specific product segments analyzed are Acupuncture Needles, Aspirating Needles, Biopsy Needles, Blood Collection Needles, Blunt Needles, Bone Marrow ...

OTCPicks.com: OTCPicks.com Stocks to Watch for Tuesday, January ... - Trading Markets (press release)

OTCPicks.com: OTCPicks.com Stocks to Watch for Tuesday, January ... Trading Markets (press release), CA - Jan 6, 2009 Simultaneously, MMU's investors garnered control of a 'to be named' secondary US public company which will be utilized for alternative MMU financed projects ... OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday ... Trading Markets (press release) all 15 news articles

GTx submits toremifene 80 mg to FDA - Bizjournals.com

SeniorJournal.com

GTx submits toremifene 80 mg to FDA Bizjournals.com, NC - Dec 30, 2008 Toremifene 80 mg met the primary endpoint of the clinical trial and other key secondary endpoints related to estrogen deficiency side effects of ADT. ... GTx Submits New Drug Application for Toremifene 80 mg for the ... WELT ONLINE GTx Submits NDA for Toremifene 80 mg for Prevention of Bone ... RTT News all 176 news articles